Primates And NotWassilios Meissner
List of bibliographic references
Number of relevant bibliographic references: 12.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000021 | Shunro Fujiwara [France, Japon] ; Lynn Uhrig [France] ; Alexis Amadon [France] ; Béchir Jarraya [France] ; Denis Le Bihan [France] | Quantification of iron in the non-human primate brain with diffusion-weighted magnetic resonance imaging |
| 000244 | Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale |
| 000369 | Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A Tale on Animal Models of Parkinson's Disease |
| 000578 | Olivier Berton [États-Unis] ; Céline Guigoni [France] ; QIN LI [France] ; Bernard H. Bioulac [France] ; Incarnation Aubert [France] ; Christian E. Gross [France] ; Ralph J. Dileone [États-Unis] ; Eric J. Nestler [États-Unis] ; Erwan Bezard [France, République populaire de Chine] | Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease |
| 000581 | Quentin Barraud [France] ; Virginie Lambrecq [France] ; Claude Forni [France] ; Steve Mcguire [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Bernard Bioulac [France] ; Emmanuel Balzamo [France] ; Erwan Bezard [France] ; François Tison [France] ; Imad Ghorayeb [France] | Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model |
| 000877 | Anne-Sophie Rolland [France] ; Maria-Trinidad Herrero [Espagne] ; Virginia Garcia-Martinez [Espagne] ; Merle Ruberg [France] ; Etienne C. Hirsch [France] ; Chantal Francois [France] | Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism |
| 000954 | X. Drouot [France] ; B. Jarraya [France] ; S. Palfi [France] | Effets fonctionnels : de la stimulation électrique du cortex moteur dans un modèle primate de la maladie de Parkinson |
| 000A35 | Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada] | Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats |
| 000C12 | M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada] | Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate |
| 000D57 | Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
| 001179 | Saliha Moussaoui [France] ; Maria-Carmen Obinu [France] ; Nadine Daniel [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Assunta Imperato [France] | The antioxidant Ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease |
| 001810 | P. Hantraye [France] ; E. Brouillet | Chronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases |
| This area was generated with Dilib version V0.6.29. |  |